Editas Medicine, Inc.
EDITNasdaqCIK 1650664HealthcareFiscal year ends Dec 31
Reports and events: 192 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0807:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-26-000093 |
| 2026-08-0516:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001650664-26-000083 |
| 2026-08-0516:03 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001650664-26-000082 |
| 2026-06-1816:28 ET | 8-K | 5.07 Shareholder vote results | 0001650664-26-000063 |
| 2026-05-2616:42 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-066317 |
| 2026-05-2608:07 ET | 8-K | 8.01 Other events | 0001104659-26-066021 |
| 2026-05-2606:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065908 |
| 2026-05-1406:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-26-000049 |
| 2026-05-0516:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001650664-26-000045 |
| 2026-05-0507:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-26-000043 |
| 2026-04-2816:34 ET | DEF 14A | Proxy statementPeriod 2026-04-28 | 0001650664-26-000037 |
| 2026-04-0716:28 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001650664-26-000030 |
| 2026-03-2707:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-26-000027 |
| 2026-03-0916:50 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001650664-26-000017 |
| 2026-03-0907:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-26-000013 |
| 2025-11-1016:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001650664-25-000156 |
| 2025-11-1007:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-25-000153 |
| 2025-10-0916:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000148 |
| 2025-09-0207:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000134 |
| 2025-08-1216:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001650664-25-000125 |
| 2025-08-1216:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-25-000123 |
| 2025-06-1206:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000106 |
| 2025-06-0217:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001650664-25-000086 |
| 2025-05-1407:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000081 |
| 2025-05-1307:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000077 |
| 2025-05-1217:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001650664-25-000073 |
| 2025-05-1216:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-25-000071 |
| 2025-04-1516:16 ET | DEF 14A | Proxy statementPeriod 2025-04-15 | 0001650664-25-000058 |
| 2025-03-2016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001650664-25-000031 |
| 2025-03-0516:21 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001650664-25-000022 |
| 2025-03-0516:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-25-000020 |
| 2025-01-1309:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001650664-25-000003 |
| 2024-12-1716:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001650664-24-000144 |
| 2024-12-1216:06 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-24-000141 |
| 2024-12-1019:32 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001650664-24-000138 |
| 2024-11-0407:36 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001650664-24-000121 |
| 2024-11-0407:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-24-000120 |
| 2024-10-2207:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001650664-24-000114 |
| 2024-10-0418:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001650664-24-000111 |
| 2024-08-0716:11 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001650664-24-000097 |
| 2024-08-0707:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-24-000094 |
| 2024-06-2717:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001650664-24-000081 |
| 2024-06-1406:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-24-000078 |
| 2024-05-3116:18 ET | 8-K | 5.07 Shareholder vote results | 0001650664-24-000050 |
| 2024-05-0816:21 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001650664-24-000037 |
| 2024-05-0807:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-24-000034 |
| 2024-04-1616:25 ET | DEF 14A | Proxy statementPeriod 2024-04-16 | 0001650664-24-000025 |
| 2024-02-2816:13 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001650664-24-000008 |
| 2024-02-2807:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-24-000006 |
| 2023-12-1309:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-23-000038 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:28 ET. Listed shows no prices and gives no investment advice.